It is reported that the anti-inflammatory effect of bilirubin plays an important role in reducing the production of proinflammatory cytokines (such as interleukin-6 and interleukin-1), which are involved in hepatic steatosis [59]. The gene discussed is IL6; the disease is fatty liver disease.